Cancer research saves lives and leads to improved outcomes for patients. But federal cancer research funding may be in jeopardy for 2026.

Context Therapeutics Inc. (NASDAQ:CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...

Mersana Therapeutics Inc. (NASDAQ:MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana ...

Erica Campbell chose a mastectomy. That choice gave her power — and helped her make peace with her biggest regret.

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here. A SCO is more than half done.

A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...

An expert discusses how long-term follow-up data from the COMMANDS trial demonstrated sustained superiority of luspatercept ...

ASCO: With hopes high, Regeneron misses mark with just one complete response in solid tumor trial so far. By Gabrielle Masson May 23, 2024 5:00pm. Regeneron Pharmaceuticals ASCO 2024 Clinical ...

ASCO showcased the payoff for new cancer medicines: longer lives. By Matthew Herper, Angus Chen, Adam Feuerstein, and Katherine MacPhail June 7, 2023. Reprints.

ASCO, for its part, tried (futilely) to help attendees navigate the murky waters. Upon registration, attendees could choose to don a red pin (keep a 6-foot distance), ...

2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors ...